Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal PD-2 with Dextrose 1.5% is a peritoneal dialysis solution. Dextrose acts as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the peritoneal cavity, which is then drained out.
DIANEAL PD-2 with 4.25% dextrose is a peritoneal dialysis solution that creates an osmotic gradient across the peritoneal membrane, promoting diffusion and convection of solutes and ultrafiltration of fluid from the blood into the peritoneal cavity. Dextrose is absorbed systemically and metabolized, providing caloric load.
Intraperitoneal: 2-2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis).
Intraperitoneal administration: 2 to 2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis) or as prescribed for automated peritoneal dialysis. Dextrose 4.25% used for ultrafiltration. Dose adjusted based on patient's peritoneal membrane transport characteristics and fluid status.
None Documented
None Documented
Not applicable; dextrose utilization is capacity-limited with half-life of ~1.5 hours in normal circulation. In peritoneal dialysis, the osmotic effect declines over dwell time (2-4 hours) as dextrose is absorbed.
Not applicable as glucose is continuously absorbed; systemic half-life of absorbed dextrose ~1-2 hours
Dextrose is completely metabolized via glycolysis and the citric acid cycle to carbon dioxide and water; <1% excreted unchanged in urine. Osmotic agent effect terminated by peritoneal absorption and systemic metabolism.
Renal, peritoneal; ~80% removed via peritoneal dialysis, remainder metabolized to CO2 and water
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution